vimarsana.com
Home
Live Updates
Arix reports NAV per share of 177 pence at end of April : vi
Arix reports NAV per share of 177 pence at end of April : vi
Arix reports NAV per share of 177 pence at end of April
Arix Bioscience PLC - London-based transatlantic venture capital company focused on investing in biotechnology companies that are advancing in life science - Reports its estimated net asset value... | May 12, 2023
Related Keywords
London ,
City Of ,
United Kingdom ,
,
Arix Bioscience ,
Alliance News ,
Alliance News Ltd ,
Will Neill ,
All Rights ,
Arix Bioscience Plc Stock Exchange ,
News ,
Information ,
Press Release ,
Prix ,
Ioscience ,
Lc ,
Transatlantic ,
Venture ,
Capital ,
Company ,
Ocused ,
N ,
Investing ,
Biotechnology ,
Companies ,
Hat ,
Fire ,
Dvancing ,
Life ,
Science ,
Reports ,
Its ,
Stimated ,
Pet ,
Sset Arix Gb00bd045071 ,